Регистрация | Вход в службу | FAQ      [?] 
Recent | Unread | Search | Authors | Tags | Export

djmonstermo rituximab [15 articles]

Recent papers added to djmonstermo library classified by the tag rituximab. You can also see everyone's rituximab.
  • Rituximab and intravenous immune globulin for desensitization during renal transplantation.
    The New England journal of medicine, Vol. 359, No. 3. (17 July 2008), pp. 242-251.
    by AA Vo, M Lukovsky, M Toyoda, J Wang, NL Reinsmoen, CH Lai, A Peng, R Villicana, SC Jordan
    posted to ivig rituximab by djmonstermo on 2008-07-20 02:23:35 as **
  • B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.
    The New England journal of medicine, Vol. 358, No. 7. (14 February 2008), pp. 676-688.
    by SL Hauser, E Waubant, DL Arnold, T Vollmer, J Antel, RJ Fox, A Bar-Or, M Panzara, N Sarkar, S Agarwal, A Langer-Gould, CH Smith,
    posted to rituximab by djmonstermo on 2008-07-20 02:23:19 as **
  • A single cycle of rituximab for the treatment of severe pemphigus.
    The New England journal of medicine, Vol. 357, No. 6. (9 August 2007), pp. 545-552.
    by P Joly, H Mouquet, JC Roujeau, M D'Incan, D Gilbert, S Jacquot, ML Gougeon, C Bedane, R Muller, B Dreno, MS Doutre, E Delaporte, C Pauwels, N Franck, F Caux, C Picard, E Tancrede-Bohin, P Bernard, F Tron, M Hertl, P Musette
    posted to rituximab by djmonstermo on 2008-07-20 02:22:03 as **
  • Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin.
    N Engl J Med, Vol. 355, No. 17. (26 October 2006), pp. 1772-1779.
    by AR Ahmed, Z Spigelman, LA Cavacini, MR Posner
    posted to ivig rituximab by djmonstermo on 2008-07-20 02:21:22 as ** along with 1 person dbs
  • Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.
    N Engl J Med, Vol. 350, No. 25. (17 June 2004), pp. 2572-2581.
    by JC Edwards, L Szczepanski, J Szechinski, A Filipowicz-Sosnowska, P Emery, DR Close, RM Stevens, T Shaw
    posted to rituximab by djmonstermo on 2008-07-19 23:00:40 as ** along with 1 person goo
  • Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy.
    Arthritis and rheumatism, Vol. 48, No. 6. (June 2003), pp. 1484-1492.
    by GJ Silverman, S Weisman
    posted to rituximab by djmonstermo on 2008-07-19 23:00:16 as **
  • Rituximab for the treatment of refractory autoimmune hemolytic anemia in children.
    Blood, Vol. 101, No. 10. (15 May 2003), pp. 3857-3861.
    by M Zecca, B Nobili, U Ramenghi, S Perrotta, G Amendola, P Rosito, M Jankovic, P Pierani, P De Stefano, MR Bonora, F Locatelli
    posted to rituximab by djmonstermo on 2008-07-19 22:59:14 as **
  • CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
    The New England journal of medicine, Vol. 346, No. 4. (24 January 2002), pp. 235-242.
    by B Coiffier, E Lepage, J Briere, R Herbrecht, H Tilly, R Bouabdallah, P Morel, E Van Den Neste, G Salles, P Gaulard, F Reyes, P Lederlin, C Gisselbrecht
    posted to rituximab by djmonstermo on 2008-07-19 22:58:59 as **
  • Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.
    Blood, Vol. 98, No. 4. (15 August 2001), pp. 952-957.
    by R Stasi, A Pagano, E Stipa, S Amadori
    posted to rituximab by djmonstermo on 2008-07-19 22:58:19 as **
  • Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 16, No. 8. (August 1998), pp. 2825-2833.
    by P McLaughlin, AJ Grillo-López, BK Link, R Levy, MS Czuczman, ME Williams, MR Heyman, I Bence-Bruckler, CA White, F Cabanillas, V Jain, AD Ho, J Lister, K Wey, D Shen, BK Dallaire
    posted to rituximab by djmonstermo on 2008-07-19 22:57:58 as **
  • Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab.
    Blood, Vol. 99, No. 4. (15 February 2002), pp. 1486-1488.
    by SL Goldberg, AL Pecora, RS Alter, MS Kroll, SD Rowley, SE Waintraub, K Imrit, RA Preti
    posted to rituximab by djmonstermo on 2008-07-19 21:34:33 as **
  • From the bench to the bedside: ways to improve rituximab efficacy.
    Blood, Vol. 104, No. 9. (1 November 2004), pp. 2635-2642.
    by G Cartron, H Watier, J Golay, P Solal-Celigny
    posted to rituximab by djmonstermo on 2008-07-19 21:33:51 as **
  • Rituximab: mechanism of action and resistance.
    Seminars in oncology, Vol. 29, No. 1 Suppl 2. (February 2002), pp. 2-9.
    by DG Maloney, B Smith, A Rose
    posted to rituximab by djmonstermo on 2008-07-19 21:33:13 as **
  • An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab.
    Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Vol. 14, No. 4. (April 2003), pp. 520-535.
    by J Boye, T Elter, A Engert
    posted to rituximab by djmonstermo on 2008-07-19 21:32:51 as **
  • Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20.
    Blood, Vol. 83, No. 2. (15 January 1994), pp. 435-445.
    by ME Reff, K Carner, KS Chambers, PC Chinn, JE Leonard, R Raab, RA Newman, N Hanna, DR Anderson
    posted to rituximab by djmonstermo on 2008-07-19 21:32:39 as **
    • Вы можете ссылаться на эту страницу по адресу: http://www.citeulike.org/user/djmonstermo/tag/rituximab

    RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.